Apyx Medical Corporation (APYX) Stock Forecast
APYX analyst forecast
as of October 17, 2026- Analyst consensus
- Strong buy 4.67 / 5 from 6 analysts
- Price target
- $6.50 average of analyst targets
- Upside to target
- +154.9% from the latest close
- Next earnings
- November 5, 2026 EPS estimate $-0.07
- 52-week range
- $2.36 – $4.86
APYX analyst ratings
6 analystsNumber of analysts at each rating.
APYX price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
APYX earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.09 | −$0.13 | −$0.07 | −$0.05 | −86.7% | 6 |
| Current fiscal year (2026) | −$0.27 | −$0.31 | −$0.23 | −$0.27 | +1.8% | 6 |
| Next fiscal year (2027) | −$0.25 | −$0.32 | −$0.21 | −$0.27 | +5.0% | 6 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
APYX revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $13.3M | $12.9M | $13.7M | +3.2% | 6 |
| Current fiscal year (2026) | $59.4M | $59.2M | $59.6M | +12.4% | 6 |
| Next fiscal year (2027) | $66.0M | $63.1M | $68.0M | +11.1% | 6 |
APYX EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
APYX revenue: reported and forecast
APYX EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.09 | −$0.09 | −$0.10 | −$0.10 | −$0.09 | +0.9% | 4 up · 0 down |
| Current fiscal year (2026) | −$0.28 | −$0.27 | −$0.27 | −$0.27 | −$0.27 | −5.4% | 4 up · 0 down |
| Next fiscal year (2027) | −$0.26 | −$0.25 | −$0.26 | −$0.26 | −$0.25 | −4.1% | 3 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
APYX earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; APYX beat in 8 of 12.
What analysts expect from APYX
6 analysts cover Apyx Medical; their consensus rating is strong buy (4.67 on a 1–5 scale, where 5 is a strong buy). The average price target is $6.50, 154.9% above the latest close of $2.55. Analysts expect earnings of −$0.27 per share for 2026, +1.8% from a year earlier. For 2027 the average estimate is −$0.25 per share on revenue of $66.0 million. Apyx Medical beat the EPS estimate in 8 of the last 12 quarters.
Related: APYX income statement, APYX key metrics, APYX chart. See the APYX stock overview for the latest quote and news.
APYX forecast FAQ
What is Apyx Medical's price target?
The average analyst price target for Apyx Medical is $6.50, 154.9% above the latest close of $2.55.
Is Apyx Medical a buy, hold or sell?
Of 6 analysts covering Apyx Medical, 4 rate it a strong buy, 2 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Apyx Medical's EPS forecast?
Analysts forecast −$0.27 per share for 2026 (range −$0.31 to −$0.23); for 2027 the estimate is −$0.25.
What is Apyx Medical's revenue forecast?
The average revenue estimate for 2026 is $59.4 million, growth of 12.4%; for 2027 it is $66.0 million.
When does Apyx Medical report earnings?
Apyx Medical is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 after the market closes; the EPS estimate is $-0.07.
Does Apyx Medical usually beat earnings estimates?
Apyx Medical reported EPS at or above the analyst estimate in 8 of the last 12 quarters.